• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Cost-Effectiveness Of Combined Treatment With Alteplase (Rt-Pa) And Cerebrolysin In Acute Ischemic Hemispheric Stroke In Austria
Worldwide, stroke is the third most common cause of death in developed countries with declining death rates. In Austria the incidence rate of stroke is 2.1 – 2.3 per thousand annually. Cerebrolysin prevents acute neuronal damage and accelerates recovery after stroke. The purpose of this analysis was to determine costs of stroke for Austria in general and to estimate the cost-effectiveness of Cerebrolysin in combination with alteplase compared to alteplase alone. The analysis should assess health economic advantages in the acute care due to a faster improvement in neurological impairment and for rehabilitation in early po...
Source: Value in Health - October 23, 2015 Category: Global & Universal Authors: E Walter, M Bauer, S Ressl Source Type: research

Thrombolysis and clinical outcome in patients with stroke after implementation of the Tyrol Stroke Pathway: a retrospective observational study
Publication date: Available online 28 November 2014 Source:The Lancet Neurology Author(s): Johann Willeit , Theresa Geley , Johannes Schöch , Heinrich Rinner , Andreas Tür , Hans Kreuzer , Norbert Thiemann , Michael Knoflach , Thomas Toell , Raimund Pechlaner , Karin Willeit , Natalie Klingler , Silvia Praxmarer , Michael Baubin , Gertrud Beck , Klaus Berek , Christian Dengg , Klaus Engelhardt , Thomas Erlacher , Thomas Fluckinger , Wilhelm Grander , Josef Grossmann , Hermann Kathrein , Norbert Kaiser , Benjamin Matosevic , Heinrich Matzak , Markus Mayr , Robert Perfler , Werner Poewe , Alexandra Rauter , Gudrun Schoen...
Source: The Lancet Neurology - December 8, 2014 Category: Neurology Source Type: research